Monica Terracciano Selected Research

diatomite

1/2021	SERS Quantification of Galunisertib Delivery in Colorectal Cancer Cells by Plasmonic-Assisted Diatomite Nanoparticles.
1/2019	In Vivo Toxicity Assessment of Hybrid Diatomite Nanovectors Using Hydra vulgaris as a Model System.
1/2018	Internalization kinetics and cytoplasmic localization of functionalized diatomite nanoparticles in cancer cells by Raman imaging.
1/2016	Nanoparticle-based strategy for personalized B-cell lymphoma therapy.
12/2015	Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery.
12/2014	Diatomite biosilica nanocarriers for siRNA transport inside cancer cells.
1/2014	Diatomite silica nanoparticles for drug delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica Terracciano Research Topics

Disease

7	Neoplasms (Cancer) 05/2022 - 01/2014
2	Polyps 12/2020 - 01/2019
2	Lymphoma (Lymphomas) 01/2016 - 04/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Brugada Syndrome 11/2020
1	Heart Diseases (Heart Disease) 11/2020
1	Bacterial Infections (Bacterial Infection) 11/2018
1	Leukemia 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Hemolysis 12/2015
1	Breast Neoplasms (Breast Cancer) 12/2015

Drug/Important Bio-Agent (IBA)

7	diatomiteIBA 01/2021 - 01/2014
3	Peptides (Polypeptides)IBA 11/2018 - 04/2015
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2015
2	SiliconIBA 12/2020 - 11/2020
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2016 - 12/2014
2	Biological ProductsIBA 01/2016 - 12/2015
1	ResveratrolIBA 05/2022
1	PolyphenolsIBA 05/2022
1	polydatinIBA 05/2022
1	Nucleic AcidsIBA 02/2021
1	Complementary DNA (cDNA)IBA 02/2021
1	Messenger RNA (mRNA)IBA 02/2021
1	LY-2157299IBA 01/2021
1	Lysine (L-Lysine)FDA Link 12/2020
1	graphene oxideIBA 11/2020
1	LigandsIBA 07/2020
1	Annexin A5IBA 07/2020
1	NucleosidesIBA 07/2020
1	Fluorescein-5-isothiocyanate (FITC)IBA 07/2020
1	TubercidinIBA 07/2020
1	GoldIBA 11/2018
1	Complement Factor B (Factor B)IBA 01/2016
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 01/2016
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 12/2015
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2015
1	amino-propyl-triethoxysilaneIBA 12/2015
1	Cell-Penetrating PeptidesIBA 12/2015
1	APTIBA 12/2015
1	Molecular Probes (Molecular Probe)IBA 04/2015
1	NanoconjugatesIBA 12/2014
1	RNA (Ribonucleic Acid)IBA 12/2014

Therapy/Procedure

2	Therapeutics 01/2016 - 12/2015